{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:02:30Z","timestamp":1783465350846,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1007\/s11894-999-0086-3","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T02:46:35Z","timestamp":1180061195000},"page":"42-49","source":"Crossref","is-referenced-by-count":79,"title":["Acetaminophen hepatotoxicity: An update"],"prefix":"10.1007","volume":"1","author":[{"given":"Craig J.","family":"McClain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Barve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Devalarja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shedlofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"86_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00004836-198802000-00016","volume":"10","author":"CJ McClain","year":"1988","unstructured":"McClain CJ, Holtzman J, Allen J, et al.: Clinical features of acetaminophen toxicity. J Clin Gastroenterol 1988, 10:76\u201380.","journal-title":"J Clin Gastroenterol"},{"key":"86_CR2","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","volume":"337","author":"FV Schiodt","year":"1997","unstructured":"Schiodt FV, Rochling FA, Casey DL, et al.: Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997, 337:1112\u20131117. This paper evaluates patients hospitalized with acetaminophen hepatotoxicity in an urban county hospital and highlights the importance of this type of liver injury as a major cause of fulminant liver failure and the importance of chronic alcohol abuse among patients with accidental overdose.","journal-title":"N Engl J Med"},{"key":"86_CR3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/0016-5085(95)90758-0","volume":"109","author":"AJ Makin","year":"1995","unstructured":"Makin AJ, Wendon J, Williams R: A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995, 109:1907\u20131916.","journal-title":"Gastroenterology"},{"key":"86_CR4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev.me.35.020184.003045","volume":"35","author":"M Black","year":"1984","unstructured":"Black M: Acetaminophen toxicity. Annu Rev Med 1984, 35:577\u2013593.","journal-title":"Annu Rev Med"},{"key":"86_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/03602539709037573","volume":"29","author":"SD Cohen","year":"1997","unstructured":"Cohen SD, Khairallah EA. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 1997, 29:59\u201377.","journal-title":"Drug Metab Rev"},{"key":"86_CR6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0041-008X(90)90174-S","volume":"104","author":"NR Pumford","year":"1990","unstructured":"Pumford NR, Hinson JA, Benson RW. Immunoblot analysis of protein containing 3-(Cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophentreated mice. Toxicol Appl Pharmacol 1990, 104:521\u2013532.","journal-title":"Toxicol Appl Pharmacol"},{"key":"86_CR7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0041-008X(90)90150-S","volume":"105","author":"RB Birge","year":"1990","unstructured":"Birge RB, Bartolone JB, Emeigh Hart SG. Acetaminophen hepatotoxicity: correspondence of selective protein arylation in human and mouse liver in vitro, in culture, and in vivo. Toxicol Appl Pharmacol 1990, 105:472\u2013482.","journal-title":"Toxicol Appl Pharmacol"},{"key":"86_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00325481.1992.11701256","volume":"91","author":"DK Rex","year":"1992","unstructured":"Rex DK, Kumar S. Recognizing acetaminophen hepatotoxicity in chronic alcoholics Postgrad Med 1992, 91:241\u2013245.","journal-title":"Postgrad Med"},{"key":"86_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","volume":"6","author":"DR Nelson","year":"1996","unstructured":"Nelson DR, Koymans L, Kamataki T, et al.: P-450 superfamily: update on news sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetic 1996, 6:1\u201342.","journal-title":"Pharmacogenetic"},{"key":"86_CR10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0003-9861(89)90278-6","volume":"271","author":"JL Raucy","year":"1989","unstructured":"Raucy JL, Lasker JM, Lieber CS, et al.: Acetaminophen activation by human liver cytochromes P-450IIEI and P-450IA2. Arch Biochem Biophys 1989, 271:270\u2013283.","journal-title":"Arch Biochem Biophys"},{"key":"86_CR11","doi-asserted-by":"crossref","first-page":"1563 1569","DOI":"10.1016\/0006-2952(93)90295-8","volume":"45","author":"KE Thummel","year":"1993","unstructured":"Thummel KE, Lee CA, Kunzel KL, et al.: Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993, 45:1563 1569.","journal-title":"Biochem Pharmacol"},{"key":"86_CR12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/tx00034a019","volume":"6","author":"CJ Patten","year":"1993","unstructured":"Patten CJ, Thomas PE, Guy RL, et al.: Cytochrome P-450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993, 6:511\u2013518.","journal-title":"Chem Res Toxicol"},{"key":"86_CR13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0016-5085(90)90963-2","volume":"99","author":"D Diaz","year":"1990","unstructured":"Diaz D, Fabre I, Daujat M, et al.: Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P-450. Gastro 1990, 99:737\u2013747.","journal-title":"Gastro"},{"key":"86_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0009-9236(97)90148-X","volume":"62","author":"T Sarich","year":"1997","unstructured":"Sarich T, Kalhorn T, Al Sayegh F, et al.: The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin. Clin Pharmacol Ther 1997, 62:21\u201328.","journal-title":"Clin Pharmacol Ther"},{"key":"86_CR15","first-page":"59","volume":"12","author":"RP Tonge","year":"1997","unstructured":"Tonge RP, Bruschi SA, Kelly EJ, et al.: Role of CYP1A2 in the hepatotoxicity of acetaminophen (abstract). ISSX Proc 1997, 12:59.","journal-title":"ISSX Proc"},{"key":"86_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0773.1995.tb00168.x","volume":"76","author":"MS Thomsen","year":"1995","unstructured":"Thomsen MS, Loft S, Roberts DW, et al.: Cytochrome 2E1 inhibitor by propylene glycol prevents acetaminophen hepatotoxicity in mice without cytochrome 1A2 inhibition. Pharmacol Toxicol 1995, 76:395\u2013399.","journal-title":"Pharmacol Toxicol"},{"key":"86_CR17","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","volume":"271","author":"SST Lee","year":"1996","unstructured":"Lee SST, Buters JTM, Pineau T, et al.: Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 1996, 271:12063\u201312067. This article unequivocally defines the role of cytochrome P-450 2E1 in acetaminophen hepatotoxicity using knockout mice.","journal-title":"J Biol Chem"},{"key":"86_CR18","first-page":"1497","volume":"273","author":"Y Dai","year":"1995","unstructured":"Dai Y, Cederbaum AI: Cytotoxicity of acetaminophen in human cytochrome P-4502E1-transfected Hep G2 cells. J Pharmacol Exp Ther 1995, 273:1497\u20131505.","journal-title":"J Pharmacol Exp Ther"},{"key":"86_CR19","first-page":"414","volume":"270","author":"T Shimada","year":"1994","unstructured":"Shimada T, Yamazaki H, Mimura M, et al.: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs. J Pharmacol Exp Ther 1994, 270:414\u2013423.","journal-title":"J Pharmacol Exp Ther"},{"key":"86_CR20","first-page":"401","volume-title":"Cytokines in Health and Disease","author":"D Hill","year":"1997","unstructured":"Hill D, Diehl AM, Tsukamoto H, et al.: Cytokines and liver disease. In Cytokines in Health and Disease, 2nd ed. Edited by Remick and Friedland. New York:Marcel Dekker; 1997 401\u2013425.","edition":"2nd ed"},{"key":"86_CR21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0041-008X(86)90051-7","volume":"86","author":"DL Laskin","year":"1986","unstructured":"Laskin DL, Pilaro AM. Potential role of activated macrophages in acetaminophen hepatotoxicity: I. Isolation and characterization of activated macrophages. Toxicol Appl Pharmacol 1986, 86:204\u2013215.","journal-title":"Toxicol Appl Pharmacol"},{"key":"86_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0041-008X(86)90052-9","volume":"86","author":"DL Laskin","year":"1986","unstructured":"Laskin DL, Pilaro AM, Ji S. Potential role of activated macrophages in acetaminophen hepatotoxicity: II. mechanism of macrophage accumulation and cativation. . Toxicol Appl Pharmacol 1986, 86:216\u2013226.","journal-title":". Toxicol Appl Pharmacol"},{"key":"86_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/taap.1995.1125","volume":"133","author":"ME Blazka","year":"1995","unstructured":"Blazka ME, Wilmer JL, Holladay SD, et al.: Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995, 133:43\u201352.","journal-title":"Toxicol Appl Pharmacol"},{"key":"86_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0928-4346(95)00207-Y","volume":"4","author":"RD Goldin","year":"1995","unstructured":"Goldin RD, Ratnayaka ID, Breach CS, et al.: Acetaminophen and macrophage activation. Int Hepatol Commum 1995, 4:16\u201318.","journal-title":"Int Hepatol Commum"},{"key":"86_CR25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/hep.1840210424","volume":"21","author":"DL Laskin","year":"1995","unstructured":"Laskin DL, Gardner CR, Price VF et al.: Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995, 21:1045\u20131050. This article highlights the role of macrophages\/Kupffer cells in acetaminophen hepatotoxicity.","journal-title":"Hepatology"},{"key":"86_CR26","unstructured":"Goldin RD, Ratnayaka ID, Breach CS, et al.: Role of macrophages in acetaminophen (Paracetamol)-induced hepatotoxicity."},{"key":"86_CR27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/hep.510270418","volume":"27","author":"F Boess","year":"1998","unstructured":"Boess F, Bopst M, Althaus R, et al.: Acetaminophen hepatotoxicity in tumor necrosis factor\/lymphotoxin-(gene knockout mice. Hepatology 1998, 27:1021\u20131029.","journal-title":"Hepatology"},{"key":"86_CR28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev.me.35.020184.003045","volume":"35","author":"M Black","year":"1984","unstructured":"Black M: Acetaminophen hepatotoxicity. Annu Rev Med 1984, 35:577\u2013593.","journal-title":"Annu Rev Med"},{"issue":"3","key":"86_CR29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-104-3-399","volume":"104","author":"LB Seef","year":"1986","unstructured":"Seef LB, Cuccherini BA, Zimmerman HJ, et al: Acetaminophen hepatotoxicity in alcoholics:A therapeutic misadventure. Ann Intern Med 1986, 104(3):399\u2013404.","journal-title":"Ann Intern Med"},{"key":"86_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.1980.03310030027020","volume":"244","author":"CJ McClain","year":"1980","unstructured":"McClain CJ, Kromhout JP, Peterson FJ, et al.: Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980, 244:251\u2013253.","journal-title":"JAMA"},{"key":"86_CR31","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.29.9.1153","volume":"29","author":"BH Lauterburg","year":"1988","unstructured":"Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: Risk factor for paracetamol hepatotoxicity Gut 1988, 29:1153\u20131157.","journal-title":"Gut"},{"key":"86_CR32","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0006-2952(97)00656-4","volume":"55","author":"J Sinclair","year":"1998","unstructured":"Sinclair J, Jeffrey E, Wrighton S, et al.: Alcohol-mediated increases in acetaminophen hepatotoxicity -Role of CYP2E and CYP3A.. Biochem Pharmacol 1998, 55:1557\u20131565.","journal-title":"Biochem Pharmacol"},{"key":"86_CR33","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/0006-2952(95)02155-8","volume":"50","author":"VE Kostrubsky","year":"1995","unstructured":"Kostrubsky VE, Wood SG, Bush MD, et al.: Acute hepatotoxicity of acetaminophen in rats treated with ethanol plus isopentenyl. Biochem Pharmacol 1995, 50:1743\u20131748.","journal-title":"Biochem Pharmacol"},{"key":"86_CR34","first-page":"57","volume":"27","author":"VE Kostrubsky","year":"1997","unstructured":"Kostrubsky VE, Szakacs JG, Jeffrey EH, et al.: Protection of ethanolmediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A.. Ann Clin Lab 1997, 27:57\u201362.","journal-title":"Ann Clin Lab"},{"key":"86_CR35","first-page":"116","volume":"16","author":"U Hoshino","year":"1995","unstructured":"Hoshino U, Kawasaki H. Urinary 6(-hydroxycortisol excretion in patients with alcoholic liver disease. Res Commun Alcohol Sub Abuse 1995, 16:116\u2013124.","journal-title":"Res Commun Alcohol Sub Abuse"},{"key":"86_CR36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/j.1875-9114.1993.tb02748.x","volume":"13","author":"CF Seifret","year":"1993","unstructured":"Seifret CF, Lucas DS, Vondracek TG, et al.: Patterns of acetaminophen use in alcoholic patients. Pharmacotherapy 1993, 13:391\u2013395.","journal-title":"Pharmacotherapy"},{"key":"86_CR37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2796.1992.tb00976.x","volume":"231","author":"LS Eriksson","year":"1992","unstructured":"Eriksson LS, Broome U, Kalin M, et al.: Case Report: Hepatotoxicity due to repeated intake of low doses of paracetamol. J Int Med 1992, 231:567\u2013570.","journal-title":"J Int Med"},{"key":"86_CR38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","volume":"272","author":"DC Whitcom","year":"1994","unstructured":"Whitcom DC, Block GD: Association of acetaminophen hepatotoxicity with fasting and ethanol use JAMA 1994, 272:1845\u20131850.","journal-title":"JAMA"},{"key":"86_CR39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2125.1986.tb02953.x","volume":"22","author":"JAHJ Critchley","year":"1986","unstructured":"Critchley JAHJ, Nimmo GR, Gregson CA, et al.: Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986, 22:649\u2013657.","journal-title":"Br J Clin Pharmacol"},{"key":"86_CR40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840220312","volume":"22","author":"HJ Zimmerman","year":"1995","unstructured":"Zimmerman HJ, Maddrey WC. Acetaminophen (Paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 1995, 22:767\u2013773. This article describes 67 patients who developed hepatic injury after ingestion of acetaminophen for therapeutic reasons. It stresses the importance of alcohol intake in enhancing therapeutic misadventures. It also stresses the unique nature of the markedly elevated AST levels in acetaminophen overdose.","journal-title":"Hepatology"},{"key":"86_CR41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thx.50.4.399","volume":"50","author":"SV Baudouin","year":"1995","unstructured":"Baudouin SV, Howdle P, O\u2018Grady JG, et al.: Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995, 50:399\u2013402.","journal-title":"Thorax"},{"key":"86_CR42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00003246-199801000-00014","volume":"26","author":"L Yip","year":"1998","unstructured":"Yip L, Dart R, Hurlbut K. Intravenous administration of oral N-acetylcysteine. Crit Care Med 1998, 26:40\u201343.","journal-title":"Crit Care Med"},{"key":"86_CR43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00003246-199801000-00005","volume":"26","author":"JL Falk","year":"1998","unstructured":"Falk JL. Oral N-acetylcysteine given intravenously for acetaminophen overdose: We shouldn\u2018t have to but we must. Crit Care Med 1998, 26:7.","journal-title":"Crit Care Med"},{"issue":"4","key":"86_CR44","first-page":"277","volume":"36","author":"AL Jones","year":"1998","unstructured":"Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: A critical review. Clin Toxicol 1998, 36(4):277\u2013285. This article reviews the role of NAC therapy in acetaminophen overdose and focuses on the utilization of this treatment late in the course of acetaminophen poisoning.","journal-title":"Clin Toxicol"},{"key":"86_CR45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1542\/peds.55.6.871","volume":"55","author":"BH Rumack","year":"1975","unstructured":"Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975, 55:871\u2013876.","journal-title":"Pediatrics"},{"key":"86_CR46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0016-5085(82)90128-7","volume":"82","author":"KV Speeg","year":"1982","unstructured":"Speeg KV, Patwardhan RV, Avant GR, et al.: Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology 1982, 82:89\u201396.","journal-title":"Gastroenterology"},{"key":"86_CR47","first-page":"550","volume":"234","author":"KV Speeg","year":"1984","unstructured":"Speeg KV, Mitchell MC, Maldonado AL. Additive protection of cimetidine and N-acetylcysteine treatment against acetaminophen-induced hepatic necrosis in the rat. J Pharm and Exp Therap 1984, 234:550\u2013554.","journal-title":"J Pharm and Exp Therap"},{"key":"86_CR48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/096032719501400311","volume":"14","author":"KK Burkhart","year":"1995","unstructured":"Burkhart KK, Janco N, Kulig KW, et al.: Cimetidine as adjunctive treatment for acetaminophen overdose. Human & Exp Toxicol 1995, 14:299\u2013304.","journal-title":"Human & Exp Toxicol"},{"key":"86_CR49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510270421","volume":"27","author":"W Bernal","year":"1998","unstructured":"Bernal W, Wendon J, Rela M, et al.: Use and outcome of liver transplantation in acetaminophen-induced liver failure. Hepatology 1998, 27:1050\u20131055. This article reviews the use of liver transplantation in acute acetaminophen-induced liver failure. Patients frequently deteriorated so rapidly that donor organs were not available. In the patients who underwent liver transplantation, 75% survived to leave the hospital. Poor prognostic indicators in acetaminophen overdose were considered to be markedly elevated prothrombin times, renal failure, hepatic encephalopathy, and acidosis. This is an excellent review of the role of liver transplantation in this form of hepatotoxicity.","journal-title":"Hepatology"},{"key":"86_CR50","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hep.1840210420","volume":"21","author":"J Devlin","year":"1995","unstructured":"Devlin J, Wendon J, Heaton N, et al.: Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology 1995, 21:1018\u20131024.","journal-title":"Hepatology"},{"key":"86_CR51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0041-1345(96)00219-9","volume":"29","author":"F-D Watanabe","year":"1997","unstructured":"Watanabe F-D, Shackleton CR, Cohen SM, et al.: Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver. Transplant Proceed 1997, 29:487\u2013488.","journal-title":"Transplant Proceed"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-999-0086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-999-0086-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-999-0086-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:10:59Z","timestamp":1707919859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-999-0086-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s11894-999-0086-3","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}